SCHEMBL38915

SCHEMBL38915

CC#CCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1897706 1.00
SCHEMBL38914 1.00
Hydrochloric Acid SCHEMBL16986444 0.96
Bicarbonate SCHEMBL5537557 0.85 GRIK1 (0.38)
SCHEMBL233379 0.79
SCHEMBL5167647 0.79
SCHEMBL55369 0.79
SCHEMBL3411076 0.79
SCHEMBL55418 0.79
SCHEMBL5167023 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 7736 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP claimed
WO-2025217099-A1 INHIBITORS FOR HYDROGEN EMBRITTLEMENT AND METHODS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-16 WO claimed
WO-2025217100-A1 METHODS AND SYSTEMS FOR STORING ODORIZED FLUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-16 WO claimed
WO-2025217091-A1 ODORANTS FOR FLUIDS, ODORIZED FLUIDS, METHODS, AND SYSTEMS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-16 WO claimed
WO-2025217089-A1 ODORIZED FLUIDS AND METHODS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-16 WO claimed
CN-119161235-A Preparation method of ethyl linalool 福建瑞昕商贸有限公司 2024-12-20 CN claimed
WO-2024211865-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY OMEGA THERAPEUTICS, INC. (US) 2024-10-10 WO claimed
EP-4392025-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS The Research Foundation for The State University of New York (US) 2024-07-03 EP claimed
US-20240199542-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2024-06-20 US claimed
EP-4232502-B1 POLYMERIC ALKYL SILICATES WACKER CHEMIE AG (DE) 2024-03-27 EP claimed
US-4820836-A ANTICOAGULANTS, ANTIULCER AGENTS SHIONOGI & CO., LTD. (JP) 1989-04-11 US claimed
EP-0136779-B1 NEW CARBACYCLIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM SANKYO COMPANY LIMITED (JP) 1988-09-14 EP claimed
EP-0257859-A2 Novel combination THE WELLCOME FOUNDATION LIMITED (GB) 1988-03-02 EP claimed
US-4699921-A CIRCULATION AMELIORATING AND ANTIULCER EFFECT MITSUBISHI YUKA PHARMACEUTICAL CO., LTD. (JP) 1987-10-13 US claimed
EP-0089769-B1 9-SUBSTITUTED CARBACYCLIN ANALOGUES THE UPJOHN COMPANY (US) 1986-10-01 EP claimed
EP-0095860-B1 POLYMERISATION OF VINYL CHLORIDE MONOMER ICI AUSTRALIA LIMITED (AU) 1986-10-01 EP claimed
EP-0171992-A2 Pharmaceuticals containing prostaglandin I2 MITSUBISHI KASEI CORPORATION (JP) 1986-02-19 EP claimed
EP-0136779-A1 New carbacyclin derivatives, processes for their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1985-04-10 EP claimed
US-4496745-A Epoxycarbacyclin derivatives, their preparation and use SANKYO COMPANY, LIMITED (JP) 1985-01-29 US claimed
EP-0051284-B1 NOVEL THIAPROSTAGLANDIN E1 DERIVATIVES, PROCESS FOR PRODUCTION THEREOF, AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS TEIJIN LIMITED (JP) 1985-01-09 EP claimed